Commentary on the 2014 BP guidelines from the panel appointed to the Eighth Joint National Committee (JNC 8)

Area of Science:

• Cardiology
• Nephrology
• Evidence-based Medicine

Background:

• The Eighth Joint National Committee (JNC 8) guideline for hypertension management has sparked significant debate.
• The JNC 8 guideline's evidence appraisal disqualified a substantial portion of prior research, relying heavily on expert opinion.
• Concerns exist regarding the JNC 8 recommendation to initiate treatment at systolic/diastolic blood pressure levels of ≥150/≥90 mmHg for adults aged 60 and older.

Purpose of the Study:

• To critically evaluate the JNC 8 hypertension management guideline.
• To compare JNC 8 recommendations with JNC 7 and other international guidelines.
• To highlight potential impacts of JNC 8 on patient cardiovascular and renal health.

Main Methods:

• Comparative analysis of the JNC 8 guideline against previous guidelines (JNC 7) and international standards.
• Evaluation of the evidence quality rating approach used in the JNC 8 guideline.
• Assessment of the clinical implications of specific JNC 8 recommendations, particularly for older adults.

Main Results:

• The JNC 8 guideline's methodology excluded approximately 98% of previous studies, leading to recommendations based solely on expert opinion.
• A specific concern is the JNC 8 recommendation to raise treatment initiation thresholds to ≥150/≥90 mmHg for adults over 60.
• The current guideline approach may not adequately address hypertension management in special populations.

Conclusions:

• The JNC 8 guideline's reliance on limited evidence and specific recommendations warrants caution.
• There is a need for regular updates (every 3-4 years) to hypertension guidelines.
• Future guidelines should incorporate modern diagnostic technologies and address special populations more comprehensively.